| MHP | hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1... |
|---|---|
| ACHPR | Agency for Health Care Policy and Research |
| A + H | accident & health [policy] |
| AHCPR | Agency for Health Care Policy and Research |
| GHPM | general health policy model |
| new combination | The new name that results from the transfer of a microorganism from one genus to another; the generic name changes but, in most cases, the specific epithet remains the same. (05 Mar 2000) |
|---|---|
| new duck disease | A contagious disease of young ducks and turkeys caused by the bacterium Pasteurella anatipestifer and characterised in ducks by ocular and nasal discharges, coughing and sneezing, and incoordination, and in turkeys by dyspnea, droopiness, lameness, and a twisted neck. Synonym: new duck disease. (05 Mar 2000) |
| new england | The geographic area of new england in general and when the specific state or states are not indicated. States usually included in this region are maine, new hampshire, vermont, massachusetts, connecticut, and rhode island. (12 Dec 1998) |
| new growth | <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous. (16 Dec 1997) |
| new guinea | Originally an island of the malay archipelago, the second largest island in the world. It divided, west new guinea becoming part of indonesia and east new guinea becoming papua new guinea. (12 Dec 1998) |
| New Hampshire rule | Pioneering American test of criminal responsibility (1871): "if the [criminal] act was the offspring of insanity, a criminal intent did not produce it." (05 Mar 2000) |
| new methylene blue | A basic thiazin dye, C18H22N3SCl, used for supravital staining of reticulocytes in blood smears. (05 Mar 2000) |
| new mutation | Redundant term for a heritable trait present in the offspring but in neither parent, i.e., not a pre-existing mutant form inherited. (05 Mar 2000) |
| new south wales | A state in southeastern Australia. Its capital is sydney. It was discovered by captain cook in 1770 and first settled at botany bay by marines and convicts in 1788. It was named by captain cook who thought its coastline resembled that of south wales. (12 Dec 1998) |
| New World leishmaniasis | A grave disease caused by Leishmania braziliensis braziliensis, endemic in southern Mexico and Central and South America, except for the equatorial region of Chile; the organism does not invade the viscera, and the disease is limited to the skin and mucous membranes, the lesions resembling the sores of cutaneous leishmaniasis caused by L. Mexicana or L. Tropica; the chancrous sores heal after a time, but some months or years later, fungating and eroding forms of ulceration may appear on the tongue and buccal or nasal mucosa; many variants of the disease exist, marked by differences in distribution, vector, epidemiology, and pathology, which suggest that it may in fact be caused by a number of closely related aetiological agents. See: espundia. Synonym: American leishmaniasis, leishmaniasis americana, nasopharyngeal leishmaniasis, New World leishmaniasis. (05 Mar 2000) |
| new yellow enzyme | The d-amino-acid oxidase found in yeast, a flavoenzyme, which contains FAD as coenzyme instead of FMN as does NADPH dehydrogenase; so-called to distinguish it from Warburg's old yellow enzyme. Compare: amino acid oxidases. (05 Mar 2000) |
| new zealand | A group of islands in the South Pacific Ocean. New Zealand flax. <botany> A myrtaceous shrub (Leptospermum scoparium) of new Zealand and Australia, the leaves of which are used as a substitute for tea. Source: Websters Dictionary (01 Mar 1998) |
| New Zealand mice | Inbred strains of mice, either black (NZB) or white (NZW), unique among strains used in experimental immunology because of their proclivity to spontaneous immunologic abnormalities and disorders including systemic lupus erythematosus similar to that found in humans. (05 Mar 2000) |
| investigational new drug | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| investigational new drug application | An application that must be submitted to a regulatory agency (the FDA in the united states) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (12 Dec 1998) |